Here are four things to know.
1. The recalled syringes and IV bags were distributed to healthcare facilities across the country between Feb. 16 and July 19.
2. The national recall excludes four states that did not receive any drug shipments from Cantrell: Connecticut, Hawaii, South Carolina and Vermont.
3. Administration of unsterile drugs could result in serious, even life-threatening infections, according to a Food and Drug Administration recall safety alert.
4. Cantrell is notifying customers of the recall and working with them to arrange the return of affected products.
More articles on supply chain:
How Dems’ ‘Better Deal’ would address drug costs: 3 notes
FDA approves Lupin’s generic skin cream
Supply chain leaders worried about potential market entry of Amazon
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
